AllStar Health Brands Inc., (ALST) Announces First Order with CO-DX (CO Diagnostics) PCR Machine for Covid-19 testing

MIAMI, FL / ACCESSWIRE / October 1, 2020 / AllStar Health Brands Inc. (OTCPINK:ALST), a specialty pharmaceutical and nutritional supplements company, is pleased to announce its first order for a PCR machine from CO-Diagnostics Inc. (CODX)

The PCR Machine order is part of a sales program to include CO-Diagnostics’ proprietary LOGIX Smart TM Coronavirus Disease 2019 (COVID 19) kits.

Dr. Daniel Bagi, President of AllStar, stated,” As the COVID-19 infection rate now seems to have increased again, we believe the need for testing will continue to increase in parallel. Allstar is very pleased to be offering the CO-Diagnostics testing system in the US, as we believe it has certain advantages over other PCR test systems, such as a proprietary blend of co-primers, which may increase the accuracy of the test results, possibly resulting in less false positives. After analyzing some of our client needs, we determined the CODX system fits perfectly into a more decentralized testing program and can give results in a matter of a couple of hours. “

About AllStar Health Brands Inc.:

AllStar Health Brands Inc. is a Nevada Corporation established in 2017 and headquartered in Miami, Florida. AllStar is a specialty Health Care Products Company dedicated to improving health and quality of life by offering select products, including medical devices, nutritional supplements, over the counter remedies, and medicines all across the Americas and Europe. AllStar’s goal is to bring additional products to the market and provide new, innovative options for better health and wellbeing.

For more information, please contact Investor Relations at (305) 423 7028.

Safe Harbor Statement

Statements about the Company’s future expectations and all other statements in this press release other than historical facts are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby.

The above information contains information relating to the Company that is based on the beliefs of the Company and/or its management, as well as assumptions made by any information currently available to the Company or its management. When used in this document, the words “anticipate,” “estimate,” “expect,” “intend,” “plans,” “projects,” and similar expressions, as they relate to the Company or its management, are intended to identify forward-looking statements. Such statements reflect the current view of the Company regarding future events and are subject to certain risks, uncertainties, and assumptions, including the risks and uncertainties, noted. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove to be incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated, expected, intended, or projected. In each instance, forward-looking information should be considered in light of the accompanying meaningful cautionary statements herein. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, the impact of competitive services and pricing, and general economic risks and uncertainties.

SOURCE: Allstar Health Brands, Inc.

View source version on accesswire.com:
https://www.accesswire.com/608705/AllStar-Health-Brands-Inc-ALST-Announces-First-Order-with-CO-DX-CO-Diagnostics-PCR-Machine-for-Covid-19-testing